More than 15% of men and women over the age of 65 may have received breast or prostate cancer screening not recommended by current guidelines.
An observational study found that adjuvant chemotherapy improves overall survival in patients with locally advanced bladder cancer.
Everolimus improved progression-free survival by 6 to 8 months compared with placebo in patients with advanced neuroendocrine tumors of the gastrointestinal tract.
Adolescent girls who live in predominantly Hispanic and high poverty communities are more likely to have had at least one HPV vaccine dose compared to girls in low poverty communities and those with different ethnic make up.
A published statement by ASCO lays out concerns about the ways in which clinical pathways, a system designed to improve the quality of care cancer patients receive, are being utilized within the US healthcare system.
Prostate cancer patients who have a more heterogeneous set of detectable circulating tumor cells are more likely to develop resistance to anti-androgen therapy, according to the results of a new study.
Men who take aspirin regularly may have a lower risk of dying from prostate cancer, according to results of a large observational study.
Progression-free survival in advanced renal cell carcinoma patients treated with cabozantinib was nearly doubled compared with those treated with everolimus, according to data from the METEOR trial.
Paid sick leave benefits could alleviate some of the financial burden patients with colorectal cancer incur during treatment and boost their job retention.
Younger women who received triptorelin to suppress ovarian function prior to chemotherapy had a greater chance of preserving fertility.